China National Medicines Corporation Ltd.
600511Pharmaceuticals
CN¥27.78−0.18%As of Oct 29vs prior close
- Market cap
- $3.1B
- P/E (TTM)
- 10.6×
- P/E (FY1)
- 9.6×
- From 52W high
- −9.63%
- EPS (LTM)
- CN¥2.62
- Revenue (LTM)
- CN¥53.7B
- Net margin
- 3.69%
Nomior Score
44
Patient ValueBottom 36% of the scored universe
Growth36
Quality48
Value68
Momentum12
Resilience71
Growth
+4.87%revenue a year over 3 fiscal years
YE22 CN¥45.5BLTM CN¥53.7B
Connections
Revenue to profitYE25
4% of revenue became net profit.